Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Competing financial interests All authors declare no conflict of financial interests
Send signals to your brain to reduce hunger and appetite
Whether your focus is recovery, body composition, gut health, performance, vitality, or healthy aging, our GLP and non-GLP peptide options allow us to create a treatment plan tailored to your individual needs
Additional Monitoring May Be Considered In Research Models Involving: Significant pigmentation variability or extensive freckling Large numbers of moles or atypical pigmentation-related findings UV-response variability and dermatological sensitivity Cardiovascular or significant cardiometabolic conditions Mood-related, psychiatric, or neuroendocrine conditions Neurological sensitivity or chronic migraines Hormonal or melanocortin-related research models Multiple concurrent melanocortin, neuroregulatory, or stimulant-related compounds Avoid or Carefully Evaluate in Research Models With: Known hypersensitivity to peptide compounds Active melanoma or suspicious pigmentation-related findings Severe uncontrolled cardiovascular disease Severe uncontrolled mood-related, psychiatric, or neurological conditions Active severe systemic illness Pregnancy or breastfeeding contexts Additional Research Considerations Because Melanotan II may influence melanocortin, pigmentation-related, and neuroendocrine signaling pathways, research protocols may warrant monitoring of: Pigmentation and melanogenesis-response variability Pigmentation variability involving freckles, moles, or existing pigmentation UV-response variability and dermatological sensitivity Appetite-, mood-, or neuroregulatory-response patterns Overall individual tolerance and pigmentation-response variability Combination protocols involving melanocortin-related, neuroregulatory, or pigmentation-focused compounds may further influence pigmentation and neuroendocrine response pathways
In particular, ECL1 and ECL3, which were disordered in the previous TMD structure, are now ordered and form a -helical conformation reminiscent of the peptide-bound GLP-1R structures
